Current Hematologic Malignancy Reports

Papers
(The TQCC of Current Hematologic Malignancy Reports is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Monoclonal Gammopathy-Associated Neuropathy119
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions30
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations24
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations20
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications19
Management of Chronic Myeloid Leukemia in Children and Young Adults18
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities17
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease17
Value in Myeloma Care: Myth or Reality16
Splicing Factor Mutations in Chronic Myelomonocytic Leukemia: Biological Consequences and Therapeutic Implications15
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer15
Targeting Apoptosis in ALL14
Transplantation and Cellular Therapy for Older Adults—The MSK Approach14
Allogeneic Transplant for CMML13
Multidisciplinary Approach to Older Adults with Hematologic Malignancies—a Paradigm Shift12
Diagnosis and Management of Pulmonary Manifestations of Telomere Biology Disorders12
Prognostic and Predictive Models in Myelofibrosis12
Multiple Myeloma: Current Clinical Landscape and Compounding Costs11
Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies11
New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications11
How Do We Manage Chronic Lymphocytic Leukemia in India11
Therapy Resistance and Disease Progression in CML: Mechanistic Links and Therapeutic Strategies10
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia10
Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders8
Adaptive and Maladaptive Clonal Hematopoiesis in Telomere Biology Disorders8
Progress and Challenges in Survivorship After Acute Myeloid Leukemia in Adults8
Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies8
CAR-T Cell Therapy: the Efficacy and Toxicity Balance8
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia8
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma8
Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia8
0.041749954223633